GlaxoSmithKline

The US Food and Drug Administration (FDA) cleared a new treatment from GlaxoSmithKline for a rare blood cancer, bolstering the UK pharmaceutical company’s push back into oncology.

India’s GlaxoSmithKline Pharmaceuticals reported an 8.6 per cent fall in its pre-tax profit for the fourth quarter on Wednesday (May 17), hurt by the government’s curbs on pricing of some essential m...

GSK said on Tuesday (May 31) it would pay up to US$3.3 billion to acquire privately held biopharmaceutical firm Affinivax to bolster its vaccine pipeline, a key area of focus as the British drugmaker ...

ALAN Jope, chief executive of Unilever, will retire his role at the end of 2023, the British consumer goods group announced Monday (Sep 26).

GSK plans to invest £1 billion (S$1.7 billion) over a decade to accelerate work on new medicines and vaccines to combat malaria, tuberculosis, HIV, neglected tropical diseases and antibiotic resistanc...

PFIZER plans to exit its 32 per cent stake in Haleon, its consumer health joint venture with British drugmaker GSK, after the business is spun off as an independent listed company in July, GSK said on...

GLAXOSMITHKLINE agreed to buy biotech company Sierra Oncology for US$1.9 billion as the UK drugmaker moves to strengthen its stable of medicines to fight cancer and prepares to spin off its consumer-h...

[BENGALURU] The US health regulator said on Tuesday (Apr 5) GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorised as a Covid-19 treatment, with data suggesting it was unlik...

[FRANKFURT] GSK racked up £1.4 billion (S$2.6 billion) in Covid-related sales in 2021, largely for antibody drug sotrovimab, as it beat quarterly forecasts in its first earnings report since rejecting...